Spinal Cord Injury clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI
open to eligible people ages 18-65
This is a safety study of human spinal cord-derived neural stem cell (HSSC) transplantation for the treatment of chronic spinal cord injury.
at UCSD
Our lead scientists for Spinal Cord Injury research studies include Joseph Ciacci, MD.
Last updated: